Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Which ablation strategy works best for persistent AF? major study seeks answers.
Disease control OngoingThis study compares three catheter ablation techniques for people with persistent atrial fibrillation (AF), a heart rhythm disorder. About 617 adults having their first ablation will be randomly assigned to one of three groups: isolating the pulmonary veins alone, adding ablation…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New Dual-Energy catheter aims to stop deadly heart rhythms
Disease control OngoingThis study tests a new catheter that uses two types of energy (radiofrequency and pulsed field) to destroy the tiny areas of heart tissue causing ventricular tachycardia, a fast and dangerous heart rhythm. Thirty patients with recurrent episodes will undergo the procedure. The go…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can a diabetes drug protect failing kidneys?
Disease control OngoingThis study looks at whether canagliflozin, a drug used for diabetes, can safely reduce protein in the urine (a sign of kidney damage) in people with advanced chronic kidney disease (CKD), including those on dialysis. About 35 adults with CKD stage 4 or 5 will take the drug for up…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Last hope drug trial for kids with fatal brain disease
Disease control OngoingThis study gives one child with Cree Leukoencephalopathy (CLE) access to an experimental drug called fosigotifator. CLE is a rare, inherited brain disease that destroys white matter and leads to early death. The drug aims to slow or stop the damage, possibly easing symptoms and i…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Last hope: experimental drug tested in single child with rare brain disease
Disease control OngoingThis study gives one patient with Cree Leukoencephalopathy, a rare and fatal brain disease, access to an experimental drug called fosigotifator. The drug aims to slow or stop the brain damage that causes severe disability and early death. Researchers will track whether the patien…
Phase: EARLY_PHASE1 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New canadian registry aims to unlock secrets of rare childhood bowel diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study creates a long-term registry for children with Hirschsprung's disease or anorectal malformations. It collects health data and family surveys during regular clinic visits to understand outcomes and improve care. No extra tests or procedures are needed. Up to 999 childre…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Could wireless sensors replace wires in the NICU?
Knowledge-focused OngoingThis study is testing whether wireless, wearable sensors can safely and accurately monitor heart rate, breathing, temperature, and oxygen levels in 75 newborn babies in the NICU. The goal is to see if these wireless devices work as well as the standard wired monitors, and if they…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny sensors could revolutionize jaundice treatment for newborns
Knowledge-focused OngoingThis study tests a new wireless sensor that continuously measures the light dose babies receive during phototherapy for jaundice. Currently, doctors check light levels only once a day with a handheld device, which can be inaccurate. The sensor aims to provide real-time data to en…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New sound sensor could help preterm babies breathe easier
Knowledge-focused OngoingThis study is testing a new, non-invasive device that listens to the breathing sounds of preterm babies to detect breathing pauses and heart rate changes. Researchers will enroll 50 preterm infants born before 32 weeks to see if the acoustic sensor can reliably monitor breathing …
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC